Oxidative stress in preretinopathic diabetes subjects and antioxidants

Diabetes Technology and Therapeutics

Volumn 14, Issue 3, 2012, Pages 257-263

  Nebbioso, Marcella ^a   Federici, Matteo ^a   Rusciano, Dario ^b   Evangelista, Mariasilvia ^a   Pescosolido, Nicola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SOOFT Italia SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FREE RADICAL; GENISTEIN; PLACEBO; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID; TIORETIN; UNCLASSIFIED DRUG; VITAMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; FEMALE; HUMAN; MALE; METABOLIC REGULATION; MORNING DOSAGE; OSCILLATORY POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA NERVE CELL;

ADULT; AGED; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; THIOCTIC ACID;

EID: 84857836518     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0172     Document Type: Article

References (38)

1. Ali TK, El-Remessy AB: Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy 2009;29:182-192.
2. Phipps JA, Fletcher EA, Vingrys AJ: Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci 2004;45:4592-4600. (Pubitemid 39564688)
3. Hancock HA, Kraft TW: Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 2004;45:1002-1008. (Pubitemid 38868404)
4. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 1997;150:523-531. (Pubitemid 27073782)
5. Stitt AW: The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol 2003;75:95-108. (Pubitemid 36798117)
6. Madsen-Bouterse SA, Kowluru RA: Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 2008;9:315-327.
7. Kowluru RA, Chan PS: Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007;2007:43603.
8. Goh S-Y, Cooper ME: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93:1143-1152. (Pubitemid 351519698)
9. Johnsen-Soriano S, Garcia-Pous M, Arnal E, Sancho-Tello M, Garcia-Delpech S, Miranda M, Bosch-Morell F, Diaz-Llopis M, Navea A, Romero FJ: Early lipoic acid intake protects retina of diabetic mice. Free Radic Res 2008;42:613-617.
10. Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE: The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci 2008;65:1-4.
11. Roberts R, Luan H, Berkowitz BA: Alpha-lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2006;47:4077-4082. (Pubitemid 46049517)
12. Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, Vom Hagen F, Nawroth P, Brownlee M, Hammes HP: Effect of R-alphalipoic acid on experimental diabetic retinopathy. Diabetologia 2006;49:1089-1096.
13. Iorio EL, Carratelli M, D'Amicantonio T: Oxidative stress and diseases. ADI Magazine 2006;4:399-404.
14. Iorio EL, Cinquanta L, Pisano RA: Diagnostic algorithm to manage oxidative stress. Aust J Cosmet Surg 2006;2:26-30.
15. Garelnabi MO, Brown WV, Le NA: Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clin Biochem 2008;41:1250-1254.
16. Kamezaki F, Yamashita K, Kubara T, Suzuki Y, Tanaka S, Rkouzuma R, Okazaki M, Tasaki H, Otuji Y: Derivatives of reactive oxygen metabolites correlates with highsensitivity C-reactive protein. J Atheroscler Thromb 2008; 15:206-212.
17. Yao D, Vlessidis AG, Evmiridis NP: Monitoring reactive oxygen species in vivo using microdialysis sampling and chemiluminescence detection as an alternative global method for determination of total antioxidant capacity. Anal Chim Acta 2002;467:133-144.
18. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI: Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003;4:225-228. (Pubitemid 36748608)
19. Haffor AS: Obstructive sleep apnea in elevated cardiac output patients: hypercapnea-induced hypoapnea. J Med Sci 2004;4:170-175.
20. Haffor AS, Al-Johany AM: Effect of heat stress, hypoxia, hypoxia-hyperoxia on free radical production in mice, Mus musculus. J Med Sci 2005;5:89-94.
21. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M: Standard for clinical electroretinography (2008 update). Doc Ophthalmol 2009;118:69-77.
22. Keogh RJ, Dunlop ME, Larkins RG: Effect of inhibition of aldose reductase on glucose flux diacylglycerol formation, protein kinase C, and phospholipase A2 activation. Metabolism 1997;46:41-47. (Pubitemid 27052022)
23. Degenhardt TP, Thorpe SR, Baynes JW: Chemical modification of proteins by methylglyoxal. Cell Mol Biol 1998;44: 1139-1145.
24. Yamagishi S, Ueda S, Matsui T, Nakamura K, Okuda S: Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. Curr Pharmacol Des 2008;14: 962-968. (Pubitemid 351753283)
25. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, Feldman EL: High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002;16:1738-1748. (Pubitemid 35340354)
26. Mohammad G, Kowluru RA: Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction. Lab Invest 2010;90:1365-1372.
27. Engerman RL, Kern TS: Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987;36: 808-812. (Pubitemid 17145301)
28. Yamagishi S, Takeuchi M, Inagaki Y, Nakamura K, Imaizumi T: Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Int J Clin Pharmacol Res 2003;23: 129-134. (Pubitemid 38821763)
29. Adamiec-Mroczek J, Oficjalska-Mlynczak J: Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes-role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2008;246:1665-1670.
30. Lopes de Jesus CC, Atallah AN, Valente O, Moça Trevisani VF: Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy. Cochrane Database Syst Rev 2008;(1): CD006695.
31. Toshihiko O, Yoji K: Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci 2006;1043:440-451.
32. Arden GB, Hamilton AM, Wilson-Holt J, Ryan S, Yudkin JS, Kurtz A: Pattern electroretinograms become abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: possible use as a screening test. Br J Ophthalmol 1986;70:330-335. (Pubitemid 16114184)
33. Luu CD, Szental JA, Lee SY, Lavanya R, Wong TY: Correlation between retinal oscillatory potentials and retinal vascular caliber in type 2 diabetes. Invest Ophthalmol Vis Sci 2010;51:482-486.
34. Kawasaki K: [Preretinopathic changes in the oscillatory potential in diabetic retina: interpretation and significance]. Nihon Ganka Gak Zasshi 1998;102:813-836. (Pubitemid 29016974)
35. Tyrberg M, Ponjavic V, Lövestam-Adrian M: Multifocal electroretinogram (mfERG) in patients with diabetes mellitus and an enlarged foveal avascular zone (FAZ). Doc Ophthalmol 2008;117:185-189.
36. Johnsen-Soriano S, Garcia-Pous M, Arnal E, Sancho-Tello M, Garcia-Delpech S, Miranda M, Bosch-Morell F, Diaz-Llopis M, Navea A, Romero FJ: Early lipoic acid intake protects retina of diabetic mice. Free Radic Res 2008;42: 613-617.
37. Sholl HP, Zrenner E: Electrophysiology in the investigation of acquired retinal disorders. Surv Ophthalmol 2000;45:29-47. (Pubitemid 30628687)
38. Nguyen TT, Wong TY: Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 2006;17: 262-268. (Pubitemid 44287473)